1.55
-0.06 (-3.73%)
| Previous Close | 1.61 |
| Open | 1.61 |
| Volume | 55,604 |
| Avg. Volume (3M) | 188,190 |
| Market Cap | 18,997,726 |
| Price / Earnings (Forward) | 1.00 |
| Price / Sales | 0.470 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Profit Margin | -86.05% |
| Operating Margin (TTM) | -130.50% |
| Diluted EPS (TTM) | -14.22 |
| Quarterly Revenue Growth (YOY) | -40.50% |
| Quarterly Earnings Growth (YOY) | 32.10% |
| Current Ratio (MRQ) | 2.09 |
| Operating Cash Flow (TTM) | -43.13 M |
| Levered Free Cash Flow (TTM) | -20.05 M |
| Return on Assets (TTM) | -52.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Allurion Technologies, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.50 |
|
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 11.67% |
| % Held by Institutions | 46.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rtw Investments, Lp | 30 Sep 2025 | 2,542,603 |
| Lri Investments, Llc | 30 Sep 2025 | 5,000 |
| 52 Weeks Range | ||
| Median | 2.50 (61.29%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Chardan Capital | 20 Nov 2025 | 2.50 (61.29%) | Hold | 1.26 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |